Escalon Medical Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ESMC research report →
Price Chart
About the company
Escalon Medical Corp. specializes in the field of ophthalmology, engaging in the development, manufacturing, promotion, and distribution of both medical devices and pharmaceutical products. Its operations span the United States and international markets.
- CEO
- Richard J. DePiano Jr.
- IPO
- 1992
- Employees
- 39
- HQ
- Wayne, PA, US
Get TickerSpark's AI analysis on ESMC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.11M
- P/E
- 1.39
- PEG
- -0.01
- P/S
- 0.10
- P/B
- 0.27
- EV/EBITDA
- 3712.80
- Div Yield
- 0.00%
- Gross Margin
- 41.48%
- Op Margin
- -7.82%
- Net Margin
- 16.18%
- ROE
- 77.88%
- ROIC
- -17.36%
Latest fiscal year · YoY change
- Revenue
- $12.05M+0.5%
- Gross Profit
- $5.51M+7.1%
- Op Income
- $133.22K
- Net Income
- $105.53K+184.2%
- EPS
- $0.00+115.9%
- OCF Growth
- +163.2%
- FCF Growth
- +159.2%
- 52W High
- $0.29
- 52W Low
- $0.14
- 50D MA
- $0.18
- 200D MA
- $0.19
- Beta
- 0.21
- RSI (14)
- 38
- Avg Volume
- 6.55K
No earnings-call transcripts are available for ESMC yet.
- Free Float
- 98.1%
- Shares Outstanding
- 7.42M
- Float Shares
- 7.27M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 13, 17 | Dogum John | other | 0 |
| Feb 13, 17 | Jacovini David James | other | 0 |
| Feb 14, 18 | DEPIANO RICHARD J | other | 1,534,883.721 |
| Feb 14, 18 | DEPIANO RICHARD J | other | 465,116.279 |
| May 12, 16 | DEPIANO RICHARD J | other | 10,000 |
| May 12, 16 | Closkey C Sean | other | 2,000 |
| May 12, 16 | NAPOLITANO LISA A | other | 2,000 |
| May 12, 16 | Trusk C Todd | other | 7,000 |
| Nov 13, 15 | Trusk C Todd | other | 0 |
| May 8, 14 | Closkey C Sean | other | 2,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ESMC coverage
Recent articles, reports, and earnings notes.
No research on ESMC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ESMC report →Escalon Medical (OTCMKTS:ESMC) Stock Breaks Above Fifty Day Moving Average – Here’s What Happened
defenseworld.net · Oct 1
Financial Analysis: Merit Medical Systems (NASDAQ:MMSI) & Escalon Medical (OTCMKTS:ESMC)
defenseworld.net · Dec 5
Reviewing Remedent (OTCMKTS:REMI) and Escalon Medical (OTCMKTS:ESMC)
defenseworld.net · Nov 25
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.